Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 24, 2011
Fourth-generation stent features bioabsorbable polymer and everolimus drug coating
-
Jan 19, 2011
Distribution agreement will allow Company to expand the service it offers customers in Japan
-
Jan 19, 2011
A live webcast and archived replay of this call will be available
-
Jan 19, 2011
Innovative left atrial appendage closure device offers alternative for patients with atrial fibrillation and strengthens Company's position in emerging structural heart markets
-
Jan 10, 2011
ORION clinical trial designed to evaluate EPIC™ Self-Expanding Nitinol Stent System for the treatment of iliac artery disease
-
Jan 5, 2011Innovative technology designed to advance deep brain stimulation therapy
Boston Scientific Corporation (NYSE: BSX) today announced it has acquired Intelect Medical, Inc., a development-stage company located in...
-
Jan 4, 2011
Article reported on a study that found about 20 percent of patients who received an implantable cardioverter defibrillator (ICD) did not meet evidence-based guidelines
-
Jan 4, 2011
Acquisition brings Boston Scientific the first fully repositionable device for percutaneous aortic valve replacement to treat severe aortic stenosis
-
Jan 3, 2011
Company prepays $600 million of debt
-
Dec 27, 2010
Company will participate in the conference on January 11, 2011. A live webcast and replay will be available.